ArticleCureus2026
One-Year Renal Recovery Following Acute Kidney Injury in Stroke Patients: A Prospective Longitudinal Follow-Up Study From Hayatabad Medical Complex Peshawar.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aim Acute kidney injury (AKI) significantly affects stroke patients, yet long-term recovery patterns remain poorly understood, especially in resource-limited settings. The incidence of AKI in stroke patients is notable, particularly in severe cases, but it is unclear whether these injuries are permanent or reversible; a critical knowledge gap for patient counseling, resource allocation, and healthcare planning where dialysis is limited. This prospective longitudinal follow-up study assessed one-year renal recovery outcomes in stroke-associated AKI, examining recovery patterns, temporal trajectories, and influencing factors. Methods This prospective longitudinal follow-up study tracked 33 stroke patients who developed AKI from an original cohort of 214 patients over 12 months (August 2023 to August 2024). Renal function was assessed every three months using serum creatinine and estimated glomerular filtration rate (eGFR). Complete recovery was defined as a return to baseline creatinine ±0.2 mg/dL or an eGFR >60 mL/min/1.73 m². Results Of the 33 patients with AKI, 31 (93.9%) completed the 12-month follow-up. Among survivors, 24/31 (77.4%) achieved complete renal recovery without intervention, while 7/31 (22.6%) had persistent mild dysfunction. Two patients died at three months with persistent dysfunction, yielding a population-level recovery rate of 72.7% (24/33) when accounting for early mortality. No patients required dialysis per the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines. Patients with hemorrhagic stroke showed recovery rates comparable to those with ischemic stroke (83.3% vs. 69.2%, p = 0.543). Patients with severe stroke had slower recovery (median 8.2 months vs. 5.1 months for moderate-to-severe cases, p = 0.041). Predictors of faster recovery included lower peak creatinine (HR, 2.63 per mg/dL decrease; 95% CI, 1.31-5.26; p = 0.006), moderate-to-severe versus severe stroke (HR, 1.89; 95% CI, 1.12-3.18; p = 0.017), and younger age (HR, 1.12 per year decrease; 95% CI, 1.02-1.23; p = 0.021). Conclusions Most stroke-related AKI demonstrates excellent spontaneous recovery within one year, supporting conservative management approaches in similar patients. Even patients with severe strokes and multiple comorbidities showed robust long-term renal recovery in Pakistani healthcare settings. However, these findings should be confirmed in larger multicenter studies, given the small sample size and potential survival bias due to early mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.